Joel Pearlman

Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy

Robert L. Avery, Joel Pearlman, Dante J. Pieramici et al. · Ophthalmology · 2006 · 798 citations

Diabetic Retinopathy, Ocular Disease, Vitreous Body +7

Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer’s disease

Yosef Koronyo, David Biggs, Ernesto Barrón et al. · JCI Insight · 2017 · 500 citations · Full text

C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration

Glenn J. Jaffe, Keith Westby, Karl G. Csaky et al. · Ophthalmology · 2020 · 406 citations

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Jeffrey S. Heier, Eleonora M. Lad, Frank G. Holz et al. · The Lancet · 2023 · 372 citations

Ocular Disease, Ophthalmology, Age-related Diseases +4

Long-term Outcomes in Patients with Retinal Vein Occlusion Treated with Ranibizumab

Peter A. Campochiaro, Raafay Sophie, Joel Pearlman et al. · Ophthalmology · 2013 · 336 citations · Full text

Ocular Disease, Vitreous Body, Ophthalmology +5